PROGYNY, INC. (PGNY) News
Filter PGNY News Items
PGNY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PGNY News Highlights
- For PGNY, its 30 day story count is now at 3.
- Over the past 5 days, the trend for PGNY's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
Latest PGNY News From Around the Web
Below are the latest news stories about PROGYNY INC that investors may wish to consider to help them evaluate PGNY as an investment opportunity.
Executive Chairman David Schlanger Sells 162,906 Shares of Progyny Inc (PGNY)On December 22, 2023, Executive Chairman David Schlanger sold 162,906 shares of Progyny Inc (NASDAQ:PGNY), as reported in a recent SEC Filing. |
24 Countries With Biggest Population DeclineThis article will list countries where population is continuously decreasing and highlight the major reasons behind this population decline. You can skip our detailed overview of the world’s population patterns and read 10 Countries With Biggest Population Decline. Recent estimates from the United Nations predict that the global population will reach approximately 8.5 billion by 2030, expand […] |
4 Unstoppable Multibaggers to Buy in 2024 and Hold for the Next DecadeEven after posting solid results so far in 2023, these four stocks still offer long-term multibagger potential. |
Returns On Capital Are Showing Encouraging Signs At Progyny (NASDAQ:PGNY)If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an... |
Does Progyny (PGNY) have a Long Runway for Growth?Polen Capital, an investment management company, released its “Polen Global SMID Company Growth Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The fund returned -6.59% gross and -6.64% net of fees compared to -3.55% return for the MSCI ACWI SMID Capitalization Index. Negative security selection drove the underperformance of the […] |
Progyny (PGNY) is an Incredible Growth Stock: 3 Reasons WhyProgyny (PGNY) is well positioned to outperform the market, as it exhibits above-average growth in financials. |
Progyny, Inc. to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 16, 2023, at 10:30 A.M. Eastern Time. A live audiocast and replay |
Progyny, Inc. (NASDAQ:PGNY) Q3 2023 Earnings Call TranscriptProgyny, Inc. (NASDAQ:PGNY) Q3 2023 Earnings Call Transcript November 7, 2023 Progyny, Inc. beats earnings expectations. Reported EPS is $0.16, expectations were $0.11. Operator: Good day, everyone, and welcome to the Progyny, Inc. Third Quarter 2023 Earnings Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, James Hart. […] |
Progyny Inc (PGNY) Posts Record Revenue in Q3 2023, Raises Full-Year GuidanceRobust Growth and Client Expansion Drive Progyny's Performance |
Progyny, Inc. Announces Third Quarter 2023 ResultsRecord Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended September 30, 2023 (“the |